31. August 2020
Areas: Europe, COVID-19, USA, Japan, Updates, New regulations and guidances "Issue" 36/20
News
24. August 2020
Areas: Europe, COVID-19, Russia, Australia, Updates, New regulations and guidances "Issue" 35/20
3. August 2020
Areas: Europe, COVID-19, USA, Australia, Updates, New regulations and guidances "Issue" 32/20
27. July 2020
Areas: Europe, Switzerland, COVID-19, USA, Australia, Updates, New regulations and guidances "Issue" 31/20
24. July 2020
Areas: MDR, MDCG updates, COVID-19, USA, Australia, Malaysia, Taiwan, Updates, New regulations and guidances "Issue" 30/20
9. July 2020
Areas: MDR, COVID-19, USA, Russia, Malaysia, Updates, New regulations and guidances "Issue" 28/20
12. June 2020
Areas: MDR, COVID-19, Canada, Malaysia, UK, Updates, New regulations and guidances "Issue" 24/20
23. May 2020
Areas: MDR, COVID-19, Singapore, USA, Russia, Kazakhstan, Brazil, Canada, Malaysia, China, Updates, New regulations and guidances "Issue" 21/20
8. May 2020
Areas: MDR, FDA, COVID-19, Japan, Taiwan, Malaysia, Updates, New regulations and guidances "Issue" 19/20
24. April 2020
Areas: MDR, COVID-19, IMDRF, Updates, New regulations and guidances "Issue" 17/20
14. April 2020
Areas: MDR, COVID-19, Further EU / MDCG Updates, China, Canada, Updates, New regulations and guidances "Issue" 16/20
26. August 2019
MDR - as of May 26, 2020, a second reporting channel for the disclosure of "non-serious events" or "expected adverse reactions" will be added for all companies.